Global Clinical Biomarker Testing Market Analysis, 2020

Name: Global Clinical Biomarker Testing Market Analysis, 2020
Creator: MarkNtel Advisors
License: https://www.marknteladvisors.com/privacy-policy

By Type (Cancer,Metabolism, Infectious Disease, Cardiology, Neurology, Immunological Disease), By Application (Drug discovery, Nutrigenomics, Toxicology Testing, Personalized medic...ine, Functional Genomics), By End-User (Pharma and Biotech Companies, Diagnostic Tool Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Research Institutes), By Country (US, Canada, Mexico, Brazil, Argentina, UK, Germany, Italy, Spain, China, India, Japan, South Korea, Australia, UAE, Saudi Arabia), By Company Read more

Healthcare
Jul 2020
Pages 178
Report Format: PDF, Excel, PPT

Get Actionable Insights for Smarter Decisions: Regional and country reports in one place pick a location for insights and Trends.

Global Clinical Biomarker Testing Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Clinical Biomarker Testing market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

The growing aging population coupled with rising rates of obesity are the major factors for the growth of biomarker testing. Other factors include emerging number of cancer therapies, advancement of bioinformatics. These reasons are expected to further drive the growth of clinical biomarker testing growth during 2020-25. According to MarkNtel Advisors’ research report titled “Global Clinical Biomarker Testing Market Analysis, 2020”, the Global Clinical Biomarker Testing market is anticipated to grow at a substantial CAGR during 2020-25. However, the high cost of cancer biomarker testing is currently restraining the market growth.

Cancer Immunotherapy Segment Acquired a Prominent Market Share
The cancer immunotherapy segment growth is constantly escalating owing to the rising prevalence of pancreas cancer, stomach cancer, breast cancer, collateral cancer, and prostate cancer. Advancement of diagnosing techniques such as transcriptomic, genomics, proteomics and metabolomics is expected to propel the growth of biomarker testing market during 2020-25. Rising awareness in healthcare professionals for an early diagnosing procedure and a rise in government funding for treatment of different diseases are expected to bolster the demand for clinical biomarker testing during the forecast period as stated in the MarkNtel Advisors’ research report “Global Clinical Biomarker Testing Market Analysis, 2020”.

Europe and North America Gained a Substantial Market Share
The demand for personalized medicines is bolstering in the European and American region, therefore, driving the Clinical Biomarker Testing market. Furthermore, emerging need for toxicology technologies, extensive R&D activities is driving the demand for clinical biomarker testing in Europe and North America. Therefore, Europe and North America held a maximum share in 2019. However, the Asia-Pacific region has immense growth potential due to increasing number of clinical laboratories in countries such as India and China.

According to MarkNtel Advisors, Abbott Laboratories, Adaptive Biotechnologies, Becton Dickinson, Bio-Rad Laboratories, Agilent Technologies, Hologic, Merck and Co., Thermofisher Scientific, Danaher Corporation, AbbVie Inc. are few of the leading players in the Global Clinical Biomarker Testing Market.

Key Questions Answered in the Market Research Report

What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Global Clinical Biomarker Testing Market?
What are the region wise industry size, growth drivers and challenges key market trends?
What are the key innovations, technology upgrades, opportunities, regulations in the Global Clinical Biomarker Testing Market?
Who are the key competitors or market players and how they perform in Global Clinical Biomarker Testing Market on the basis of competitive benchmarking matrix?
What are the key results derived from the market surveys conducted during the course of Global Clinical Biomarker Testing Market study?

Market Outlook, Segmentation and Statistics

Market Size & Analysis
- By Revenues
Market Share & Analysis
- By Type
  - Cancer
  - Metabolism
  - Infectious Disease
  - Cardiology
  - Neurology
  - Immunological Disease
- By Application
  - Drug discovery
  - Nutrigenomics
  - Toxicology Testing
  - Personalized medicine
  - Functional Genomics
- By End-User
  - Pharma and Biotech Companies
  - Diagnostic Tool Companies
  - Healthcare IT/Big Data Companies
  - Clinical Laboratories
  - Research Institutes
- By Region
  - North America
    - US
    - Canada
    - Mexico
  - South America
    - Brazil
    - Argentina
  - Europe
    - UK
    - Germany
    - France
    - Italy
    - Spain
  - Asia-Pacific
    - China
    - India
    - Japan
    - Australia
    - South Korea
  - Middle East & Africa
    - UAE
    - Saudi Arabia
- By Company
  - Revenue Shares
  - Strategic Factorial Indexing
  - Competitor Placement in Markntel Quadrant
North America Clinical Biomarker Testing Market Outlook, 2015-2025F (USD Million)
South America Clinical Biomarker Testing Market Outlook, 2015-2025F (USD Million)
Europe Clinical Biomarker Testing Market Outlook, 2015-2025F (USD Million)
Middle East & Africa Clinical Biomarker Testing Market Outlook, 2015-2025F (USD Million)
Asia-Pacific Clinical Biomarker Testing Market Outlook, 2015-2025F (USD Million)
Global Clinical Biomarker Testing Market Policies, Regulations, Product Standard
Global Clinical Biomarker Testing Market Intellectual Property Rights Analysis
Global Clinical Biomarker Testing Market Hotspots & Opportunities
Competition Outlook
- Competitor Wise Growth Strategies
- Company Profiles

Frequently Asked Questions

Q. What is the historical year, base year and forecast year considered in the research report on Global Clinical Biomarker Testing Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.

Q. What would be the growth rate or CAGR of the Global Clinical Biomarker Testing Market during 2020-25?
A. The growth rate of the Global Clinical Biomarker Testing Market during 2020-25 is forecast to be less than 10%.

Q. Who are the key competitors or players operating in the Global Clinical Biomarker Testing Market?
A. Abbott Laboratories, Adaptive Biotechnologies, Becton Dickinson, Bio-Rad Laboratories, Agilent Technologies, Hologic, Merck and Co., Thermofisher Scientific, Danaher Corporation, AbbVie Inc. are few of the leading players in the Global Clinical Biomarker Testing Market.

Q. Which end-user segment would emerge as an opportunity area for players in Global Clinical Biomarker Testing Market?
A. The hospital testing and clinical testing segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.

Q. Which region would emerge as an opportunity area for players in Global Clinical Biomarker Testing Market?
A. North America region grabbed a significant market share continues to grow at the highest CAGR, presenting immense opportunities for manufacturers and suppliers of the Global Clinical Biomarker Testing Market.

Frequently Asked Questions

A. The hospital testing and clinical testing segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.

Introduction
1. Product Definition
2. Research Process
3. Glossary
4. Market Segmentation
Executive Summary
Expert Verbatim- Interview Excerpts of 10 industry experts
Global Clinical Biomarker Testing Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
    1. Cancer
    2. Metabolism
    3. Infectious Disease
    4. Cardiology
    5. Neurology
    6. Immunological Disease
  2. By Application
    1. Drug discovery
    2. Nutrigenomics
    3. Toxicology Testing
    4. Personalized medicine
    5. Functional Genomics
  3. By End-User
    1. Pharma and Biotech Companies
    2. Diagnostic Tool Companies
    3. Healthcare IT/Big Data Companies
    4. Clinical Laboratories
    5. Research Institutes
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. Asia-Pacific
    5. Middle East & Africa
  5. By Company
    1. Revenue Shares
    2. Strategic Factorial Indexing
    3. Competitor Placement in MarkNtel Quadrant
North America Clinical Biomarker Testing Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
  2. By Application
  3. By End-User
  4. By Country
    1. US
    2. Canada
    3. Mexico
3. US Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
4. Canada Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
5. Mexico Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
South America Clinical Biomarker Testing Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
  2. By Application
  3. By End-User
  4. By Country
    1. Brazil
    2. Argentina
    3. Others
3. Brazil Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
4. Argentina Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
Europe Clinical Biomarker Testing Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
  2. By Application
  3. By End-User
  4. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Others
3. UK Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
4. Germany Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
5. France Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
6. Italy Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
7. Spain Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
Asia-Pacific Clinical Biomarker Testing Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
  2. By Application
  3. By End-User
  4. By Country
    1. China
    2. India
    3. Japan
    4. Australia
    5. South Korea
    6. Others
3. China Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
4. India Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
5. Japan Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
6. Australia Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
7. South Korea Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
Middle East and Africa Clinical Biomarker Testing Market Outlook, 2015-2025F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Type
  2. By Application
  3. By End-User
  4. By Country
    1. UAE
    2. Saudi Arabia
    3. Others
3. UAE Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
4. Saudi Arabia Clinical Biomarker Testing Market Outlook, 2015-2025F
  1. Market Size & Analysis
    1. By Revenues
Global Clinical Biomarker Testing Dynamics
1. Drivers
2. Challenges
3. Impact Analysis
Global Clinical Biomarker Testing Regulations, Product Standards
Global Clinical Biomarker Testing Value Chain Analysis
Global Clinical Biomarker Testing Intellectual Property Rights Analysis
Global Clinical Biomarker Testing Hotspots & Opportunities
Competition Outlook
1. Competitor Wise Growth Strategies
  1. Product Portfolio
  2. Brand Specialization
  3. Target Markets
  4. Research & Development
  5. Strategic Alliances & Initiatives
2. Company Profiles
  1. Abbott Laboratories
  2. Adaptive Biotechnologies
  3. Becton Dickinson
  4. Bio-Rad Laboratories
  5. Agilent Technologies
  6. Hologic
  7. Merck and Co.
  8. Thermofisher Scientiifc
  9. Danaher Corporation
  10. AbbVie Inc.
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying

Talk to our Consultant

Request Customization

Global / Regional Reports

Report Walkthrough

Related Reports

Customization Offered

Our Clients

Client Testimonial

The decision to outsource a significant portion of clinical trials to India was initially met with skepticism, but with the assistance of MarkNtel, the process proved to be highly successful. MarkNtel likely played a crucial role in facilitating and managing the outsourcing venture, providing expertise, guidance, and possibly acting as a liaison between your company and the outsourced partners in India.

Head of Planning - A FMCG Company

We were very impressed with the thoroughness of the research, professionalism, calibre, detail, and robustness of the work, as well as with how MarkNtel went above and beyond to encourage us to consider our strategies and the originality of the analytical framework used to support them, to name just a few facets of the engagement. We were pleasantly surprised by the analysis's results and recommendations, which well above our initial projections.

Business head - Pharmaceutical Giant

We have cross-validated your information with our sales and marketing guys on the field and your findings represent the true picture. This is the first time a research firm has not shown us disappointment. I like the way your team keeps sharing the new developments or changes in the industry even after the completion of our mutual contract. I really appreciate your client caring attitude. Keep going!

Country Head - (A leading Latin American Energy Conglomerate)

Head of Planning - A FMCG Company

Business head - Pharmaceutical Giant

Country Head - (A leading Latin American Energy Conglomerate)

Global Clinical Biomarker Testing Market Analysis, 2020

Global Clinical Biomarker Testing Market Statistics and Insights, 2025